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A B S T R A CT  
Replacement therapy for chronic kidney disease using 
haemodialysis involves the elimination of excessive toxic 
fluids and toxic metabolic end products from the body. 
Worldwide, gender significant differences exist with regard to 
the epidemiological aspect, evolution and blood parameters of 
chronic renal failure disease. In the present retrospective 
study, 289 medical files of adult patients (154 men and 135 
women) aged 20 to 78 years were investigated to understand 
the relationship between gender difference and blood 
parameters in patients with chronic renal failure undergoing 
haemodialysis in north western Algeria. Our results revealed 
significant higher levels of haemoglobin (p=0.003), 
haematocrit (p=0.005), creatinine (p<0.001) and uric acid 
(p=0.037) in men comparing to women. However, women 
serum samples were characterized by higher significant level 
of platelets (p=0.002). No significant differences (p˃0.005) 
were observed between the two genders regarding the other 
parameters of blood count formula, liver function parameters, 
urea, mineral status (calcemia and phosphoremia), basic 
biochemical levels (glycaemia and lipids), C-reactive 
protein (CRP) and parathyroid hormone (PTH). In dialysis 
patients, and despite the fact that some serum parameters vary 
significantly, the majority of the parameters recorded were 
often high in the males compared to the female gender. This 
finding may be due to the existence of specific confounding 
prognostic factors for each sex, which may or may not 
compensate for each other, therefore, ultimately, leading to 
overall non-significance. 
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1 Introduction 
Currently, nearly 2.6 million patients worldwide have different kidney diseases [1], the major problem in 
these patients remains the risk of developing different complications such as heart disease, high blood 
pressure, anaemia and inflammation [2]. However, when kidney failure becomes chronic, through gradual 
progression - over a period of weeks, months or years - the kidneys slowly stop functioning, there is a 
terminal kidney disease [3]. An adequate treatment protocol must take into account gender differences, 
since not only demographic characteristics, but also many clinical, laboratory and therapeutic parameters 
can affect morbidity and mortality and differ considerably between the two genders [4]. 
Haemodialysis is one of the kidney replacement treatments [5]. The technique plays an essential role in the 
process of extracorporeal elimination of waste when the kidneys are affected. The haemodialysis procedure 
is performed two to three times a week over two to four hours. The duration of dialysis varies according 
to many factors, including kidney function, the waste amount in the body, the level of salts and body weight 
[6]. Our present study was performed in order to understand the relationship between gender difference 
and blood parameters in patients with chronic renal failure undergoing haemodialysis in north western 
Algeria. 
2 Materials and Methods 
2.1 Patients and study localization  
This retrospective study involved two hundred and eighty-nine blood samples, of patients with chronic 
renal failure undergoing haemodialysis, collected from Tabia Hospital “BOURAS Miloud”, in Sidi-Bel-
Abbès, north-western Algeria. Ethical approval for performing the present study was taken from the 
scientific council of the faculty of natural and life sciences, Djillali LIABES University. The patient's medical 
records were checked respecting the rules of anonymity with protecting the personal information of each 
patient.  
2.2 Studied parameters 
Results of blood samples analysis were taken from patients’ medical record. The following blood parameters 
were considered: blood count formula, liver function parameters (ASAT and ALAT), renal parameters 
(urea, creatinine and uric acid), mineral status (calcemia and phosphoremia), basic biochemical levels 
(glycaemia and lipids), C-reactive protein (CRP) and parathyroid hormone (PTH).  
2.3 Statistical Analysis  
The Statistical Package for Social Sciences (SPSS, version 24.0) program was used in this study. All values 
were expressed as Mean ± Standard Deviation (SD). The Student ‘t’ test for independent variables was 
considered significant when the probability (p) was less than 0.05 (p> 0.05).  
3 Results and Discussion 
The study population consisted of 154 men and 135 women, their mean age was 52.52±12.31 years 
(48.51±9.88 years, in men vs. 57.09±13.22 years, in women) and ranged from 20 to 78 years. Our results 
show a significant higher level (p<0.05) of haemoglobin, haematocrit and platelets in men comparing to 
women (table 1). However, higher non-significant levels of red blood cells, mean cell volume (MCV), 
leucocytes and mean corpuscular haemoglobin concentration (MCHC) were observed in women. Several 
studies have shown that there are differences between males and females in hematological parameters like 
sodium, potassium, calcium, creatinine, amylase, total protein, albumin, phosphate and lever enzymes. The 
levels of these parameters are usually higher in males. Parameters like platelets, eosinophils, basophils, red 
cell counts, hemoglobin and hematocrit tend to vary among sex and age group [7, 8].  
Our results indicate that the vast majority of our patients have anaemia. Similar results were reported by 
Anees et al., 2018 who found that 91.2% of kidney failure patients had anaemia [9]. Indeed, the endogenous 
117 
 
 ISSN: 2456-7108  
Available online at Journals.aijr.in 
Meghraoui et al., Adv. J.  Grad.  Res.; Vol. 8, Issue 1, pp: 115-120, July 2020 
erythropoietin deficiency, the uremic inhibitors and the shortened red blood cells survival are the main 
cause of anaemia in haemodialysis patients [10]. However, anaemia aggravates exercise tolerance, cognitive 
competence and reduces quality of life in dialysis patients [11]. Several authors stated that the haemoglobin 
is one of the most affected haematological parameters in patients with kidney failure [2, 12, 13]. 
Table 1. Comparison of the complete blood count results between men and women 
 All patients Males Females p value* 
Red Blood Cells (millions/mm3) 3.69±0.17 3.62±0.74 
[4.2-5.7] 
3.78±0.25 
[4.0-5.3] 
0.518 
Haemoglobin (g/100ml) 10.66±1.97 10.99±1.81 
[14.0-17.0] 
10.28±2.08 
[12.5-15.5] 
0.003 
Haematocrit (%) 37.77±7.28 33.22±7.14 
[40-52] 
29.84±7.07 
[37-46] 
0.005 
Mean Cell Volume (MCV) (µ3) 88.76±11.98 88.14±12.93 
[80-95] 
89.55±10.79 
[80-95] 
0.603 
Leukocytes (/mm3x1000) 6.66±0.24 6.46±0.23 
[4.0-10.0] 
6.91±0.25 
[4.0-10.0] 
0.203 
Mean Corpuscular Haemoglobin 
Concentration (MCHC) (%) 
26.11±1.22 25.66±1.32 
[30-35] 
27.08±1.04 
[30-35] 
0.779 
Platelets (/mm3x1000) 214.43±71.87 200.65±75.70 
[150-400] 
229.82±64.25 
[150-400] 
0.002 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
According to Pandian et al. (2017), anaemia due to a reduction in haemoglobin levels is a common 
complication encountered in dialysis patients [14]. The same conclusions have been done by Suega et al. 
(2005) [15] and Bhatta et al. (2011) [16]. 
Table 2 displayed a comparison of liver enzymes serum levels (Aspartate Transaminase “ASAT” and 
Alanine Aminotransferase “ALAT”) between men and women. Normal low rates have been recorded for 
both enzymes in our patients, although, these rates are high in women comparing to men. Several recent 
studies have revealed that serum ALT levels are lower in dialysis patients [17-19]. All the same, in their 
study done in Italy, Fabrizi et al. (2001) found lower ASAT and ALAT levels among dialysis patients 
compared to predialysis ones [20]. According to van Beek et al. (2013), in haemodialysis patients, the 
observed variations between males and females in ASAT and ALAT serum may be partly due to hereditary 
factors and are impacted by the biological effects of chronic renal failure disease and the patient 
environment. The latter would comprise metabolic risk issues such as dyslipidaemia, inflammation, alcohol 
use, smoking, vitamin D levels and coffee consumption [21]. 
Table 2. Effect of sex differences on the liver transaminases 
 All patients Males Females p value* 
Alanine Aminotransferase (ALAT) (IU/L) 14.34±1.04 13.71±0.99 
[8-45] 
14.98±1.09 
[6-35] 
0.565 
Aspartate Transaminase (ASAT) (IU/L) 19.37±1.01 17.92±0.86 
[10-40] 
20.94±1.14 
[10-35] 
0.142 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
 In numerous studies, a strong association was observed between serum creatinine and serum urea levels 
among renal failure patients undergoing or not haemodialysis. However, both serum creatinine and serum 
urea are accepted putative indices to evaluate the renal functions. Our results, summarized in table3, indicate 
a higher significant level of urea, creatinine (p<0.001) and uric acid (p=0.037) in male dialysis patients 
comparing to females. These results are consistent with those of Ul Amin et al. (2014) where creatinine and 
urea levels were commonly higher in male dialysis patients than women [22]. Several Scientifics affirmed 
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that, every day, 2% of creatine is converted into creatinine, that's why the normal values for creatinine are 
in the range of (male: 20 to 25 mg/kg/day; female 15 to 20 mg/kg/day) [2]. This difference between males 
and females is explained by the greater muscle mass in men comparing to women. 
Table 3. Comparison of renal function tests between the two genders 
 All patients Males Females p value* 
Urea (g/L) 1.57±0.50 1.65±0.53 
[0.1-0.55] 
1.47±0.45 
[0.1-0.55] 
0.772 
Creatinine (mg/L) 81.30±2.85 89.97±3.03 
[5-15] 
71.75±2.30 
[5-15] 
<0.001 
Uric acid (mg/L) 47.19±2.17 50.04±2.30 
[40-60] 
43.66±1.95 
[40-60] 
0.037 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
As shown in table 4, we compared serum calcium and phosphorus between males and females undergoing 
dialysis. Our results displayed normal higher non-significant levels of both serum calcium (p=0.430) and 
phosphorus (p=0.519) in males comparing to females. There is controversy over the association of gender 
with the mineral parameters in patients with chronic kidney disease. In contrast to our study, Artan et al. 
(2016) reported that control of serum phosphorus was better in women compared to men [4]. The main 
reasons are probably the efficiency of dialysis, which results in greater phosphorus clearance, compliance 
with a strict diet and/or better adhesion to phosphate binders [4]. According to the JSDT clinical practice 
guidelines, the management of serum phosphorus is of greater priority [23]. Collinson et al. (2014) reported 
that the gender difference may be a factor influencing the control of chronic kidney disease-related minerals 
[24].  
Table 4. Gender effect on mineral status 
 All patients Males Females p value* 
Calcemia (mg/L) 99.75±3.29 102.57±2.68 
[85-105] 
96.62±3.88 
[85-105] 
0.430 
Phosphoremia (mg/L) 37.39±2.32 38.36±2.46 
[30-40] 
36.15±2.12 
[30-40] 
0.519 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
Our outcomes about glycaemia, total cholesterol and triglycerides indicates normal range of these 
parameters in our population (table 5), except the higher level of triglycerides in females. However, the 
comparison between males and females revealed non-significant differences (p˃0.005). Similar results have 
been reported by Rusul Arif et al. (2000) [3]. All, the same no significant effect of gender was observed on 
C-reactive protein (CRP) and parathyroid hormone (PTH) levels in our study population (table 6). Though, 
the levels of these two parameters in men were higher than those observed in women in accordance with 
previous reports [25]. The explanation for this result is ambiguous; probably, poorer control of phosphorus 
serum level and less regular vitamin D usage may explain this conclusion. 
Table 5. Comparison of basic biochemical parameters between males and females 
 All patients Males Females p value* 
Fasting glycaemia (g/L) 1.02±0.51 0.99±0.48 
[0.8-1.0] 
1.06±0.54 
[0.8-1.0] 
0.321 
Total cholesterol (g/L) 2.39±1.21 1.42±0.38 
[1.15-2.7] 
3.79±1.89 
[1.15-2.7] 
0.179 
Triglycerides (g/L) 1.31±0.80 1.36±0.12 
[0.6-1.7] 
1.24±0.84 
[0.6-1.7] 
0.453 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
119 
 
 ISSN: 2456-7108  
Available online at Journals.aijr.in 
Meghraoui et al., Adv. J.  Grad.  Res.; Vol. 8, Issue 1, pp: 115-120, July 2020 
Table 6. Comparison of C-reactive protein and Parathyroid hormone levels between men and women 
 All patients Males Females p value* 
C-reactive protein (CRP) (mg/L) 339.25±19.05 422.66±20.41 
[<10] 
267.76±17.32 
[<10] 
0.166 
Parathyroid hormone (PTH) (pg/L) 463.55±48.77 499.19±57.24 
[132.0-640.0] 
392.26±26.58 
[132.0-640.0] 
0.623 
(*) p value of student t test, a p<0.05 was considered as significant. In square brackets, the target values. 
4 Conclusion 
In dialysis patients, and under the light of above results, serum parameters vary significantly and the majority 
were often higher in males compared to the female gender. A firm relationship was observed between male 
gender and higher levels of hemoglobin, hematocrits, renal function tests, mineral status and parathyroid 
hormone. It is imperative to raise the feasibility of using single target for all patients undergoing 
hemodialysis under different conditions. 
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